Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalva Benjamin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|August 21, 2009
Transperitoneal laparoscopic radical nephrectomy is an effective procedure for large (more than 7 cm) renal massesBoris Chertin, Shalva Benjamin, Pethachia Reissman, et al.
The Journal of Urology|October 28, 2008
Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-GuerinAbraham Ami Sidi, Patricia Ohana, Shalva Benjamin, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 25, 2015
The value of testicular ultrasound in the prediction of the type and size of testicular tumorsAbraham Shtricker, David Silver, Elias Sorin, et al.
The Journal of Urology|December 18, 2013
DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancerOfer N Gofrit, Shalva Benjamin, Sarel Halachmi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|August 21, 2009
Transperitoneal laparoscopic radical nephrectomy is an effective procedure for large (more than 7 cm) renal massesBoris Chertin, Shalva Benjamin, Pethachia Reissman, et al.
The Journal of Urology|October 28, 2008
Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-GuerinAbraham Ami Sidi, Patricia Ohana, Shalva Benjamin, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 25, 2015
The value of testicular ultrasound in the prediction of the type and size of testicular tumorsAbraham Shtricker, David Silver, Elias Sorin, et al.
The Journal of Urology|December 18, 2013
DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancerOfer N Gofrit, Shalva Benjamin, Sarel Halachmi, et al.
Pageof 2